Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report

Tomonori Nukariya; Toshiki Tezuka; Shohei Okusa; Ryotaro Okochi; Yuto Sakai; Yoshihiro Nihei; Jin Nakahara; Morinobu Seki

doi:10.14802/jmd.24247

Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report

J Mov Disord. 2025 Jan 6. doi: 10.14802/jmd.24247. Online ahead of print.

Authors

Tomonori Nukariya^{1

2

3}, Toshiki Tezuka^{1

2

3}, Shohei Okusa^{1

2

3}, Ryotaro Okochi^{1

2

3}, Yuto Sakai^{1

2

3}, Yoshihiro Nihei^{1

2

3}, Jin Nakahara^{1

2

3}, Morinobu Seki^{1

2

3}

Affiliations

¹ Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
² Parkinson's Disease Center, Keio University Hospital, Tokyo, Japan.
³ Center for Parkinson's disease Research, Keio University, Tokyo, Japan.

PMID: 39757596
DOI: 10.14802/jmd.24247

No abstract available